earnings
XE
NASDAQ · XERS
Xeris Biopharma Holdings, Inc.
Healthcare · Biotechnology
$10.35
Up+$0.11 (+1.06%)
Updated Nov 5, 2026, 12:55 AM
SID Score
7.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.16B
- P/E ratio
- -34.21
- Dividend yield
- 0.00%
- 52-week range
- $5.25 – $11.42
- Volume
- 3.29M
- Avg. volume
- 2.44M
Price performance · XERS
XERS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
XERS closed at $10.35 after 20 trading sessions, up 2.37% for the selected period.
- Last close
- $10.35
- Period change
- +2.37%
- Period low
- $9.77
- Period high
- $11.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $10.17 | $10.56 | $10.17 | $10.35 | 3.29M |
| Nov 2, 2026 | $10.71 | $10.72 | $10.08 | $10.17 | 2.31M |
| Oct 30, 2026 | $10.81 | $10.8782 | $10.515 | $10.71 | 1.55M |
| Oct 29, 2026 | $10.80 | $10.945 | $10.705 | $10.75 | 1.75M |
| Oct 28, 2026 | $10.45 | $10.75 | $10.39 | $10.64 | 1.45M |
| Oct 27, 2026 | $10.16 | $10.485 | $10.10 | $10.45 | 1.52M |
| Oct 26, 2026 | $10.22 | $10.405 | $10.12 | $10.21 | 1.91M |
| Oct 23, 2026 | $10.85 | $10.85 | $10.06 | $10.20 | 2.37M |
| Oct 22, 2026 | $10.81 | $10.98 | $10.67 | $10.86 | 1.41M |
| Oct 21, 2026 | $11.14 | $11.275 | $10.7701 | $10.785 | 1.68M |
| Oct 20, 2026 | $11.005 | $11.35 | $10.9639 | $11.13 | 2.9M |
| Oct 19, 2026 | $10.34 | $11.415 | $10.34 | $10.95 | 4.34M |
| Oct 16, 2026 | $10.04 | $10.33 | $9.8401 | $10.31 | 2.29M |
| Oct 15, 2026 | $9.77 | $10.18 | $9.76 | $10.07 | 1.94M |
| Oct 14, 2026 | $10.08 | $10.39 | $9.73 | $9.77 | 2.37M |
| Oct 13, 2026 | $10.41 | $10.50 | $10.15 | $10.20 | 2.22M |
| Oct 12, 2026 | $10.465 | $10.55 | $10.325 | $10.46 | 1.33M |
| Oct 9, 2026 | $10.15 | $10.60 | $10.07 | $10.48 | 3M |
| Oct 8, 2026 | $10.10 | $10.35 | $10.00 | $10.19 | 1.98M |
| Oct 7, 2026 | $10.00 | $10.27 | $9.91 | $10.11 | 2.22M |
Latest XERS news
The latest Smart Investors Daily articles mentioning XERS.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…